Pharma Focus Asia

Akoya Biosciences Plans to Open Operations and Manufacturing Centre in Massachusetts, USA

Introduction:

Akoya Biosciences is planning to launch its state-of-the-art operations and manufacturing centre of excellence in Massachusetts, USA.

Features: 

The newly established operations and manufacturing centre is strategically designed to accommodate the rising demand for spatial biology solutions, particularly the increased use of the PhenoCycler®-Fusion and PhenoImager® HT platforms.

This state-of-the-art facility covers an area of 32,000 square feet, integrates research and development (R&D), manufacturing, quality control, warehouse space, and distribution under one roof. 

By co-locating these critical functional areas, the centre enhances responsiveness to the growing market demand, streamlines the manufacturing process, optimises supply chain efficiency, and supports initiatives aimed at improving gross margins.

Now fully operational, the centre's primary focus will be on the manufacturing and quality control of molecular barcoded antibodies and the associated reagents, ensuring high-quality products.

Specifications:

Name    Akoya Biosciences
Type      New Construction


 

magazine-slider-imageCytiva - Supor Prime filtersMFA + MMA 20244th Annual Cleaning Validation 20242nd Annual Pharma Impurity Conclave 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference